Shree Ganesh Remedies Ltd. | Small-cap | Healthcare
₹581.35
-2.07%
| Shree Ganesh Stock Comparison:
Shree Ganesh vs Sun PharmaceuticalShree Ganesh vs Divi's LaboratoriesShree Ganesh vs Sun Pharma AdvancedShree Ganesh vs Aarti DrugsShree Ganesh vs Sequent ScientificShree Ganesh vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 244.3M
Gross Profit 185.9M 76.08%
Operating Income 73.6M 30.14%
Net Income 65.9M 26.97%

Balance Sheet Metrics

Total Assets 1.9B
Total Liabilities 467.9M
Shareholders Equity 1.5B
Debt to Equity 0.32

Cash Flow Metrics

Revenue & Profitability Trend

Shree Ganesh Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.1B1.3B902.2M712.9M490.8M
Cost of Goods Sold i358.7M584.8M471.6M370.5M220.2M
Gross Profit i727.2M674.2M430.6M342.4M270.6M
Gross Margin % i67.0%53.6%47.7%48.0%55.1%
Operating Expenses
Research & Development i-235.0K---
Selling, General & Administrative i-22.9M18.7M9.0M8.0M
Other Operating Expenses i233.9M128.1M88.2M81.3M50.6M
Total Operating Expenses i233.9M151.2M106.9M90.3M58.7M
Operating Income i296.5M357.0M203.1M151.0M112.6M
Operating Margin % i27.3%28.4%22.5%21.2%22.9%
Non-Operating Items
Interest Income i-646.0K1.3M1.5M1.6M
Interest Expense i21.1M5.5M446.0K1.0M304.0K
Other Non-Operating Income-----
Pre-tax Income i312.7M381.6M225.8M180.1M129.5M
Income Tax i82.0M100.5M55.6M46.1M32.0M
Effective Tax Rate % i26.2%26.3%24.6%25.6%24.7%
Net Income i230.7M281.1M170.2M134.0M97.5M
Net Margin % i21.2%22.3%18.9%18.8%19.9%
Key Metrics
EBITDA i429.4M445.8M265.4M213.0M157.1M
EPS (Basic) i₹17.96₹22.34₹14.01₹11.08₹9.68
EPS (Diluted) i₹17.96₹22.34₹14.01₹11.08₹9.68
Basic Shares Outstanding i1284432112583000121438961209266710077452
Diluted Shares Outstanding i1284432112583000121438961209266710077452

Income Statement Trend

Shree Ganesh Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i99.5M158.5M86.5M38.8M34.7M
Short-term Investments i189.1M46.6M25.0M-31.2M
Accounts Receivable i222.7M203.3M279.2M183.8M133.3M
Inventory i220.2M249.9M181.8M136.4M127.1M
Other Current Assets40.9M1.0K--1.0K1.0K
Total Current Assets i775.8M702.0M642.9M449.1M379.9M
Non-Current Assets
Property, Plant & Equipment i949.7M19.6M13.1M11.8M22.4M
Goodwill i4.7M3.6M7.4M8.5M11.7M
Intangible Assets i4.7M3.6M3.6M931.0K445.0K
Long-term Investments-----
Other Non-Current Assets89.6M-1.0K3.0K500.0K963.1K
Total Non-Current Assets i1.1B1.0B795.4M321.1M226.1M
Total Assets i1.9B1.7B1.4B770.2M606.0M
Liabilities
Current Liabilities
Accounts Payable i59.7M81.9M145.3M94.7M62.1M
Short-term Debt i87.8M72.1M25.8M-2.1M
Current Portion of Long-term Debt-----
Other Current Liabilities1.7M-1.0K--415.0K
Total Current Liabilities i161.8M186.8M237.4M150.4M101.9M
Non-Current Liabilities
Long-term Debt i296.1M292.4M309.3M--
Deferred Tax Liabilities i5.3M5.8M-2.0M2.4M
Other Non-Current Liabilities10.0K----1.0K
Total Non-Current Liabilities i306.0M301.6M311.6M4.0M4.1M
Total Liabilities i467.9M488.4M549.0M154.4M105.9M
Equity
Common Stock i128.4M128.4M125.1M120.1M100.1M
Retained Earnings i-867.2M610.6M447.2M331.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.5B1.2B889.4M615.7M500.0M
Key Metrics
Total Debt i383.8M364.5M335.1M02.1M
Working Capital i613.9M515.2M405.5M298.7M278.0M

Balance Sheet Composition

Shree Ganesh Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i312.7M381.6M225.8M180.1M129.5M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i3.6M16.9M-93.2M-87.0M-24.1M
Operating Cash Flow i337.1M403.9M135.2M36.8M-831.6K
Investing Activities
Capital Expenditures i-231.8M-311.3M-515.5M-153.3M-90.0K
Acquisitions i0----172.0K
Investment Purchases i-128.3M-44.1M0-174.0K-10.0M
Investment Sales i3.3M24.8M034.3M840.0K
Investing Cash Flow i-356.8M-330.7M-535.7M-119.1M-8.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i--6.3M-6.0M-16.1M-
Debt Issuance i-----
Debt Repayment i----788.0K-5.0M
Financing Cash Flow i1.0K67.4M104.0M-10.9M-6.6M
Free Cash Flow i74.7M-6.9M-345.7M-19.1M33.0M
Net Change in Cash i-19.6M140.6M-296.6M-93.2M-16.0M

Cash Flow Trend

Shree Ganesh Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 33.00
Price to Book 4.97
Price to Sales 6.64
PEG Ratio -1.27

Profitability Ratios

Profit Margin 20.16%
Operating Margin 19.77%
Return on Equity 15.89%
Return on Assets 12.02%

Financial Health

Current Ratio 4.79
Debt to Equity 26.44
Beta 0.25

Per Share Data

EPS (TTM) ₹17.01
Book Value per Share ₹113.00
Revenue per Share ₹84.44

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sgrl7.2B33.004.9715.89%20.16%26.44
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.7910.9314.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.8B23.753.2812.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.